Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis

In Vivo

Volumn 20, Issue 3, 2006, Pages 377-380

  Zardi, Enrico Maria ^a   Picardi, Antonio ^a   Ambrosino, Giovanni ^b   Fazio, Vito Michele ^a   Dobrina, Aldo ^c   Frego, Mauro ^b   Afeltra, Antonella ^a   Lumachi, Franco ^b  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Color Doppler ultrasonography; Hepatic microcircle; Iloprost; Portal flow; Raynaud's phenomenon; Systemic sclerosis

Indexed keywords

ILOPROST; PROSTACYCLIN DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VOLUME; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLUSHING; HEADACHE; HEMODYNAMICS; HIGH RISK PATIENT; HUMAN; LIVER BLOOD FLOW; LIVER DYSFUNCTION; LIVER PERFUSION; LIVER PROTECTION; MALE; MICROANGIOPATHY; MICROCIRCULATION; NAUSEA; RAYNAUD PHENOMENON; RISK ASSESSMENT; SIDE EFFECT; STUDENT T TEST; SYSTEMIC SCLEROSIS; THROMBOSIS; VASCULAR PATENCY; VOMITING;

EID: 33646823258     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Moncada S, Gryglewski R, Bunting S and Vane JR: An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263: 663-665, 1976.
2. Machherndl S, Kneussl M, Baumgartner H et al: Long-term treatment of pulmonary hypertension with aerosolized iloprost. Eur Respir J 17: 8-13, 2001.
3. Ceru S, Pancera P, Sansone S et al: Effects of five-day versus one-day infusion of iloprost on the peripheral microcirculation in patients with systemic sclerosis. Clin Exp Rheumatol 15: 381-383, 19975.
4. 2 exchange and liver energy metabolism in hyperdynamic porcine endotoxemia: effects of iloprost. Intensive Care Med 26: 1531-1539, 2000.
5. Changani KK, Fuller BJ, Bell JD et al: Improved preservation solutions for organ storage: a dynamic study of hepatic metabolism. Transplantation 68: 345-355, 1999.
6. Chen HM, Chen MF and Shyr MH: Prostacyclin analog (OP-2507) attenuates hepatic microcirculatory derangement, energy depletion, and lipid peroxidation in a rat model of reperfusion injury. J Surg Res 80: 333-338, 1998.
7. Zardi EM, Picardi A, Ambrosino G et al: Hemodynamic effects of a PGI2 analog (iloprost) on portal flow velocity and volume and visceral artery circulation in patients with lower limb arteriopathy. Ultrasound Med Biol 29: 209-213, 2003.
8. Kojima H, Uemura M, Sakurai S et al: Clinical features of liver disturbance in rheumatoid diseases: clinicopathological study with special reference to the cause of liver disturbance. J Gastroenterol 37: 617-625, 2002.
9. Kahaleh MB: Raynaud's phenomenon and vascular disease in scleroderma. Curr Opin Rheumatol 6: 621-627, 1994.
10. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23: 581-590, 1980.
11. Gandhi CR, Stephenson K and Olson MS: Endothelin, a potent peptide agonist in the liver. J Biol Chem 265: 17432-17435, 1990.
12. Kawada N, Tran-Thi TA, Klein H and Decker K: The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur J Biochem 213: 815-823, 1993.
13. Zhang JX, Pegoli W Jr and Clemens MG: Endothelin-1 induces direct constriction of hepatic sinusoids. Am J Physiol 266: G624-632, 1994.
14. Bauer C, Walcher F, Kalweit U et al: Role of nitric oxide in the regulation of the hepatic microcirculation in vivo. J Hepatol 27: 1089-1095, 1997.
15. McCuskey RS: Morphological mechanisms for regulating blood flow through hepatic sinusoids. Liver 20: 3-7, 2000.
16. De Nucci G, Thomas R, D'Orleans-Juste P et al: Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 85: 9797-9800, 1988.
17. Konturek SJ and Pawlik W: Physiology and pharmacology of prostaglandins. Dig Dis Sci 31: 6S-19S, 1986.
18. Eisenhut T, Sinha B, Grottrup-Wolfers E et al: Prostacyclin analogs suppress the synthesis of tumor necrosis factor-alpha in LPS-stimulated human peripheral blood mononuclear cells. Immunopharmacology 26: 259-264, 1993.
19. Neumann UP, Kaisers U, Langrehr JM et al: Reduction of reperfusion injury with prostacyclin 12 after liver transplantation. Transplant Proc 31: 1029-1030, 1999.
20. Neumann UP, Kaisers U, Langrehr JM et al: Administration of prostacyclin after liver transplantation: a placebo controlled randomized trial. Clin Transplant 14: 70-74, 2000.
21. Klein M, Geoghegan J, Wangemann R et al: Preconditioning of donor livers with prostaglandin I2 before retrieval decreases hepatocellular ischemia-reperfusion injury. Transplantation 67: 1128-1132, 1999.
22. Kurokawa T and Takagi H: Mechanism and prevention of ischemia-reperfusion injury. Transplant Proc 31: 1775-1776, 1999.
23. 2 synthase inhibitor on the graft survival in pig liver transplantation. J Surg Res 60: 232-238, 1996.
24. Kobayashi H, Nonami T, Kurokawa T et al: Role of endogenous nitric oxide in ischemia-reperfusion injury in rat liver. J Surg Res 59: 772-779, 1995.
25. Pannen BH: New insights into the regulation of hepatic blood flow after ischemia and reperfusion. Anesth Analg 94: 1448-1457, 2002.
26. Garcia-Pagan JC, Zhang JX, Sonin N et al: Ischemia/reperfusion induces an increase in the hepatic portal vasoconstrictive response to endothelin-1. Shock 11: 325-329, 1999.
27. Kaisers U, Neumann U, Kuhlen R et al: Nitroglycerin versus epoprostenol: effects on hemodynamics, oxygen delivery, and hepatic venous oxygenation after liver transplantation. Liver Transpl Surg 2: 455-460, 1996.
28. Schulz BG and Muller B: Iloprost antagonizes endothelin-induced vasoconstriction in macro- and microcirculation. Eicosanoids. 3: 135-138, 1990.
29. Herold C, Reck T, Ott R et al: Changes in hepatic hemodynamics after orthotopic liver transplantation: color Doppler sonography. Abdom Imag 26: 32-35, 2001.